Literature DB >> 25822386

Diagnosis and management of sodium disorders: hyponatremia and hypernatremia.

Michael M Braun1, Craig H Barstow2, Natasha J Pyzocha1.   

Abstract

Hyponatremia and hypernatremia are common findings in the inpatient and outpatient settings. Sodium disorders are associated with an increased risk of morbidity and mortality. Plasma osmolality plays a critical role in the pathophysiology and treatment of sodium disorders. Hyponatremia and hypernatremia are classified based on volume status (hypovolemia, euvolemia, and hypervolemia). Sodium disorders are diagnosed by findings from the history, physical examination, laboratory studies, and evaluation of volume status. Treatment is based on symptoms and underlying causes. In general, hyponatremia is treated with fluid restriction (in the setting of euvolemia), isotonic saline (in hypovolemia), and diuresis (in hypervolemia). A combination of these therapies may be needed based on the presentation. Hypertonic saline is used to treat severe symptomatic hyponatremia. Medications such as vaptans may have a role in the treatment of euvolemic and hypervolemic hyponatremia. The treatment of hypernatremia involves correcting the underlying cause and correcting the free water deficit.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25822386

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  24 in total

1.  Rate of Correction of Hypernatremia and Health Outcomes in Critically Ill Patients.

Authors:  Kinsuk Chauhan; Pattharawin Pattharanitima; Niralee Patel; Aine Duffy; Aparna Saha; Kumardeep Chaudhary; Neha Debnath; Tielman Van Vleck; Lili Chan; Girish N Nadkarni; Steven G Coca
Journal:  Clin J Am Soc Nephrol       Date:  2019-04-04       Impact factor: 8.237

2.  Comparison of measured and calculated osmolality levels.

Authors:  Ezgi Kar; Evin Kocatürk; Zeynep Küskü Kiraz; Bahar Demiryürek; I Özkan Alataş
Journal:  Clin Exp Nephrol       Date:  2020-01-25       Impact factor: 2.801

3.  Assessment of Selected Serum Electrolyte and Associated Risk Factors in Diabetic Patients.

Authors:  Shiferaw Bekele Woyesa; Waqtola Cheneke Gebisa; Delebo Lefebo Anshebo
Journal:  Diabetes Metab Syndr Obes       Date:  2019-12-31       Impact factor: 3.168

4.  Agreement of Potassium, Sodium, Glucose, and Hemoglobin Measured by Blood Gas Analyzer With Dry Chemistry Analyzer and Complete Blood Count Analyzer: A Two-Center Retrospective Analysis.

Authors:  Hongxiang Xie; Shiyu Lv; Sufeng Chen; Zhenzhen Pang; Deli Ye; Jianzhuang Guo; Wanju Xu; Weidong Jin
Journal:  Front Med (Lausanne)       Date:  2022-04-01

Review 5.  The Trafficking of the Water Channel Aquaporin-2 in Renal Principal Cells-a Potential Target for Pharmacological Intervention in Cardiovascular Diseases.

Authors:  Tanja Vukićević; Maike Schulz; Dörte Faust; Enno Klussmann
Journal:  Front Pharmacol       Date:  2016-02-11       Impact factor: 5.810

6.  Hydration health literacy in the elderly.

Authors:  Dominic Picetti; Stephen Foster; Amanda K Pangle; Amy Schrader; Masil George; Jeanne Y Wei; Gohar Azhar
Journal:  Nutr Healthy Aging       Date:  2017-12-07

7.  Central Diabetes Insipidus and Hyperglycemic Hyperosmolar State Following Accidental Carbon Monoxide Poisoning.

Authors:  Zain Ul Abideen; Syed Nayer Mahmud; Amna Rasheed; Yusaf Farooq Qasim; Furqan Ali
Journal:  Cureus       Date:  2017-06-03

Review 8.  Pathophysiology of Hyponatremia in Children.

Authors:  Jakub Zieg
Journal:  Front Pediatr       Date:  2017-10-16       Impact factor: 3.418

9.  Iatrogenic Dysnatremias in Children with Acute Gastroenteritis in High-Income Countries: A Systematic Review.

Authors:  Silviu Grisaru; Jianling Xie; Susan Samuel; Stephen B Freedman
Journal:  Front Pediatr       Date:  2017-10-06       Impact factor: 3.418

10.  Extreme hypernatremia as a probable cause of fatal arrhythmia: a case report.

Authors:  Maulee Hiromi Arambewela; Noel P Somasundaram; Chaminda Garusinghe
Journal:  J Med Case Rep       Date:  2016-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.